Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Redcentric's Alan Aubrey raises stake

Fri 30 Oct 2026 12:17

(Sharecast News) - Redcentric revealed on Friday that non-executive director Alan Aubrey had acquired 69,164 ordinary shares in the AIM-listed IT managed services firm. Aubrey, who joined the board of Redcentric in July 2022, purchased the shares at an average price of 86.75p, for a total value of £59,999.77.

Following the transaction, Aubrey holds a beneficial interest in 106,396 ordinary Redcentric shares.

As of 1530 GMT, Redcentric shares were up 0.92% at 88.31p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Redcentric (RCN) Director name: Aubrey,Alan John Amount purchased: 69,164 @ 86.75p Value: £59,999.77

Kazera Global (KZG) Director name: Jennings,Richard Amount purchased: 4,086,800 @ 1.00p Value: £40,868.00

The Schiehallion Fund Limited Npv (MNTN) Director name: Colquhoun,Wendy Amount purchased: 18,137 @ $2.19 Value: $39,720.03

Kazera Global (KZG) Director name: Dulieu,Paul Amount purchased: 2,130,000 @ 1.40p Value: £29,820.00

Top Director Sells

Share this article

Related Sharecast Articles

Thu 29 Oct 2026 13:33
Director dealings: Raspberry Pi CEO snaps up shares
(Sharecast News) - Raspberry Pi revealed on Thursday that chief executive Eben Upton had acquired 5,000 ordinary shares in the FTSE 250-listed single-board computers designer and developer.
Wed 28 Oct 2026 15:26
Director dealings: Primary Health Properties CEO raises stake
(Sharecast News) - Primary Health Properties revealed on Wednesday that chief executive Mark Davies had acquired 140,759 ordinary shares in the FTSE 250-listed real estate investment trust.
Tue 27 Oct 2026 12:36
Director dealings: Porvair CEO increases shareholding
(Sharecast News) - Porvair revealed on Tuesday that chief executive Hooman Caman Javvi had acquired 5,946 ordinary shares in the London-listed filtration and environmental technology firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statements | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026